Singh P, Harris PC, Sas DJ, Lieske JC. The genetics of kidney stone disease and nephrocalcinosis. Nat Rev Nephrol. 2022;18(4):224–40.
Raina R, Vijayvargiya N, Khooblall A, Melachuri M, Deshpande S, Sharma D, Mathur K, Arora M, Sethi SK, Sandhu S. Pediatric atypical hemolytic uremic syndrome advances. Cells. 2021;10(12):3580.
Article CAS PubMed PubMed Central Google Scholar
Kagan M, Pleniceanu O, Vivante A. The genetic basis of congenital anomalies of the kidney and urinary tract. Pediatr Nephrol. 2022;37:2231.
Torra R, Furlano M, Ortiz A, Ars E. Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports. Clin Kidney J. 2021;14(8):1879–85.
Article PubMed PubMed Central Google Scholar
Participants KC. Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2022;101(6):1126–41.
Vaisitti T, Peritore D, Magistroni P, Ricci A, Lombardini L, Gringeri E, Catalano S, Spada M, Sciveres M, Di Giorgio A, et al. The frequency of rare and monogenic diseases in pediatric organ transplant recipients in Italy. Orphanet J Rare Dis. 2021;16(1):374.
Article PubMed PubMed Central Google Scholar
Kramer A, Boenink R, Stel VS, Santiuste de Pablos C, Tomovic F, Golan E, Kerschbaum J, Seyahi N, Ioanou K, Beltran P, et al. The ERA-EDTA Registry Annual Report 2018: a summary. Clin Kidney J. 2021;14(1):107–23.
Domingo-Gallego A, Pybus M, Bullich G, Furlano M, Ejarque-Vila L, Lorente-Grandoso L, Ruiz P, Fraga G, Lopez Gonzalez M, Pinero-Fernandez JA, et al. Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players. Nephrol Dial Transpl. 2022;37(4):687–96.
Tullus K, Webb H, Bagga A. Management of steroid-resistant nephrotic syndrome in children and adolescents. Lancet Child Adolesc Health. 2018;2(12):880–90.
Kienzl-Wagner K, Waldegger S, Schneeberger S. Disease recurrence-the sword of damocles in kidney transplantation for primary focal segmental glomerulosclerosis. Front Immunol. 2019;10:1669.
Article CAS PubMed PubMed Central Google Scholar
Metry EL, Garrelfs SF, Peters-Sengers H, Hulton SA, Acquaviva C, Bacchetta J, Beck BB, Collard L, Deschenes G, Franssen C, et al. Long-term transplantation outcomes in patients with primary hyperoxaluria type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry. Kidney Int Rep. 2022;7(2):210–20.
Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393(10174):919–35.
Gross O, Tonshoff B, Weber LT, Pape L, Latta K, Fehrenbach H, Lange-Sperandio B, Zappel H, Hoyer P, Staude H, et al. A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome. Kidney Int. 2020;97(6):1275–86.
Article CAS PubMed Google Scholar
Vaisitti T, Sorbini M, Callegari M, Kalantari S, Bracciama V, Arruga F, Vanzino SB, Rendine S, Togliatto G, Giachino D, et al. Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience. J Nephrol. 2021;34(5):1767–81.
Article CAS PubMed Google Scholar
Ahn YH, Lee C, Kim NKD, Park E, Kang HG, Ha IS, Park WY, Cheong HI. Targeted exome sequencing provided comprehensive genetic diagnosis of congenital anomalies of the kidney and urinary tract. J Clin Med. 2020;9(3):751.
Article CAS PubMed PubMed Central Google Scholar
Madariaga L, Moriniere V, Jeanpierre C, Bouvier R, Loget P, Martinovic J, Dechelotte P, Leporrier N, Thauvin-Robinet C, Jensen UB, et al. Severe prenatal renal anomalies associated with mutations in HNF1B or PAX2 genes. Clin J Am Soc Nephrol. 2013;8(7):1179–87.
Article CAS PubMed PubMed Central Google Scholar
van der Ven AT, Connaughton DM, Ityel H, Mann N, Nakayama M, Chen J, Vivante A, Hwang DY, Schulz J, Braun DA, et al. Whole-exome sequencing identifies causative mutations in families with congenital anomalies of the kidney and urinary tract. J Am Soc Nephrol. 2018;29(9):2348–61.
Article PubMed PubMed Central Google Scholar
Ishiwa S, Sato M, Morisada N, Nishi K, Kanamori T, Okutsu M, Ogura M, Sako M, Kosuga M, Kamei K, et al. Association between the clinical presentation of congenital anomalies of the kidney and urinary tract (CAKUT) and gene mutations: an analysis of 66 patients at a single institution. Pediatr Nephrol. 2019;34(8):1457–64.
Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H, Li Y, Zhang J, Nestor J, Krithivasan P, et al. Diagnostic utility of exome sequencing for kidney disease. N Engl J Med. 2019;380(2):142–51.
Article CAS PubMed Google Scholar
Bullich G, Domingo-Gallego A, Vargas I, Ruiz P, Lorente-Grandoso L, Furlano M, Fraga G, Madrid A, Ariceta G, Borregan M, et al. A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseases. Kidney Int. 2018;94(2):363–71.
Jayasinghe K, Stark Z, Kerr PG, Gaff C, Martyn M, Whitlam J, Creighton B, Donaldson E, Hunter M, Jarmolowicz A, et al. Clinical impact of genomic testing in patients with suspected monogenic kidney disease. Genet Med. 2021;23(1):183–91.
Halbritter J, Baum M, Hynes AM, Rice SJ, Thwaites DT, Gucev ZS, Fisher B, Spaneas L, Porath JD, Braun DA, et al. Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol. 2015;26(3):543–51.
Article CAS PubMed Google Scholar
Braun DA, Lawson JA, Gee HY, Halbritter J, Shril S, Tan W, Stein D, Wassner AJ, Ferguson MA, Gucev Z, et al. Prevalence of monogenic causes in pediatric patients with nephrolithiasis or nephrocalcinosis. Clin J Am Soc Nephrol. 2016;11(4):664–72.
Article CAS PubMed PubMed Central Google Scholar
Daga A, Majmundar AJ, Braun DA, Gee HY, Lawson JA, Shril S, Jobst-Schwan T, Vivante A, Schapiro D, Tan W, et al. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int. 2018;93(1):204–13.
Article CAS PubMed Google Scholar
Sinha R, Pradhan S, Banerjee S, Jahan A, Akhtar S, Pahari A, Raut S, Parakh P, Basu S, Srivastava P, et al. Whole-exome sequencing and variant spectrum in children with suspected inherited renal tubular disorder: the East India Tubulopathy Gene Study. Pediatr Nephrol. 2022;37(8):1811–36.
Huang L, Qi C, Zhu G, Ding J, Yuan L, Sun J, He X, Wang X. Genetic testing enables a precision medicine approach for nephrolithiasis and nephrocalcinosis in pediatrics: a single-center cohort. Mol Genet Genom. 2022;297:1049.
Ashton EJ, Legrand A, Benoit V, Roncelin I, Venisse A, Zennaro MC, Jeunemaitre X, Iancu D, Van’t Hoff WG, Walsh SB, et al. Simultaneous sequencing of 37 genes identified causative mutations in the majority of children with renal tubulopathies. Kidney Int. 2018;93(4):961–7.
Article CAS PubMed Google Scholar
Portoles J, Huerta A, Arjona E, Gavela E, Aguera M, Jimenez C, Cavero T, Marrero D, Rodriguez de Cordoba S, Diekmann F, et al. Characteristics, management and outcomes of atypical haemolytic uraemic syndrome in kidney transplant patients: a retrospective national study. Clin Kidney J. 2021;14(4):1173–80.
Article CAS PubMed Google Scholar
Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, Couzi L, Jourde-Chiche N, Chatelet V, Gaisne R, et al. Use of highly individualized complement blockade has revolutionized clinical outcomes after kidney transplantation and renal epidemiology of atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2019;30(12):2449–63.
Article CAS PubMed PubMed Central Google Scholar
Siedlecki AM, Isbel N, Vande Walle J, James Eggleston J, Cohen DJ. Global a HUSR: eculizumab use for kidney transplantation in patients with a diagnosis of atypical hemolytic uremic syndrome. Kidney Int Rep. 2019;4(3):434–46.
Yepez VA, Gusic M, Kopajtich R, Mertes C, Smith NH, Alston CL, Ban R, Beblo S, Berutti R, Blessing H, et al. Clinical implementation of RNA sequencing for Mendelian disease diagnostics. Genome Med. 2022;14(1):38.
Article CAS PubMed PubMed Central Google Scholar
Rodenburg RJ. The functional genomics laboratory: functional validation of genetic variants. J Inherit Metab Dis. 2018;41(3):297–307.
Article CAS PubMed PubMed Central Google Scholar
Robertson AJ, Tan NB, Spurdle AB, Metke-Jimenez A, Sullivan C, Waddell N. Re-analysis of genomic data: an overview of the mechanisms and complexities of clinical adoption. Genet Med. 2022;24(4):798–810.
Article CAS PubMed Google Scholar
David KL, Best RG, Brenman LM, Bush L, Deignan JL, Flannery D, Hoffman JD, Holm I, Miller DT, O’Leary J, et al. Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2019;21(4):769–71.
留言 (0)